Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
about
Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled studyCancer related fatigue syndrome in neoplastic diseasesHerpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human DiseaseChronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndromeTreatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.Cytokine expression provides clues to the pathophysiology of Gulf War illness and myalgic encephalomyelitisB-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance TreatmentSerum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue SyndromeChronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy?Humoral Immunity Profiling of Subjects with Myalgic Encephalomyelitis Using a Random Peptide Microarray Differentiates Cases from Controls with High Specificity and Sensitivity.Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab.Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins.Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls.Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.Chronic fatigue syndrome/myalgic encephalomyelitis: an update.Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
P2860
Q21089923-49B1CE66-3123-4E4B-A398-AE3F0128FEBFQ26795579-6D6AC5DF-989F-400C-AE39-8E5429D4AD08Q31152067-AAE6DAE5-ED74-42C2-8A1B-0DA2855028D5Q33737919-9E08A6E6-61C6-4EEB-9096-88021C9A3B79Q34161527-C4C1BEB8-A020-4283-B0D8-BFB0078ABEE8Q34680436-AE694704-66C1-4BD3-9F2B-D7B0F0A1346BQ34687563-DB1EDABC-A18B-498A-B09B-C784820698FFQ35060449-DF3E9F47-4E27-413C-AB76-88C82A3572ACQ35541231-92B7095E-DC28-4C77-A69B-EC8D0EE01CF7Q35680023-90BE20E3-DD37-4E5A-8168-FDBBF2193DC7Q36106681-9EFF4E57-CBE5-4365-8699-935FA44C252AQ36735025-E40DDD43-0B98-42BD-99DC-D93FD0E1875DQ37678427-49BE8695-6F03-4CD6-B0F1-2450FE2EC4C2Q39096114-066573F8-2E9A-4A4B-A210-2746A26BD8E9Q40097140-2A769372-C7ED-4266-A494-519BB92D660CQ41852549-04E0B483-BF54-49E6-9950-97ABF39D7210Q43589508-85851AFA-0685-462C-B426-EFF3D615FD5DQ50333926-EED9049A-7AFD-4E55-BC83-FE887B2C6C9AQ51515704-C5C57DA4-6EFD-459F-92EF-17BD5DF7D339Q51733779-558E4064-5366-4A79-A2F5-6EC194E7CE0AQ55387468-62CDC7CB-7A24-46D4-8044-AED6B817A8FC
P2860
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Clinical impact of B-cell depl ...... ome: a preliminary case series
@ast
Clinical impact of B-cell depl ...... ome: a preliminary case series
@en
Clinical impact of B-cell depl ...... ome: a preliminary case series
@nl
type
label
Clinical impact of B-cell depl ...... ome: a preliminary case series
@ast
Clinical impact of B-cell depl ...... ome: a preliminary case series
@en
Clinical impact of B-cell depl ...... ome: a preliminary case series
@nl
prefLabel
Clinical impact of B-cell depl ...... ome: a preliminary case series
@ast
Clinical impact of B-cell depl ...... ome: a preliminary case series
@en
Clinical impact of B-cell depl ...... ome: a preliminary case series
@nl
P2860
P3181
P356
P1433
P1476
Clinical impact of B-cell depl ...... ome: a preliminary case series
@en
P2860
P2888
P3181
P356
10.1186/1471-2377-9-28
P407
P577
2009-01-01T00:00:00Z
P5875
P6179
1030233644